Clinical Trial: A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285655) titled 'A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD' on Dec. 11.

Brief Summary: The purpose of this study is to find out if L606 is safe and if it helps people with high blood pressure in the lungs (pulmonary hypertension) caused by interstitial lung disease (PH-ILD, WHO Group 3). One of the main ways the study will check this is by seeing if people can walk further in six minutes (called the "six-minute walk test"). Another important (secondary) goal is to see how long it takes for PH-ILD to get worse while people are taking L606. One way the study will measure this is by looking at the distance peo...